Zoekresultaten - E. D. Mikhaltsova
- Toon 1 - 2 resultaten van 2
-
1
Probability of allogeneic hematopoietic stem cell transplant failure depending on the recipient's killer immunoglobulin-like receptor genotype door U. V. Maslikova, E. G. Khamaganova, M. Yu. Drokov, I. Yu. Urybin, E. D. Mikhaltsova, L. A. Kuzmina, E. N. Parovichnikova
Gepubliceerd in 2023-03-01Introduction. Natural killers are the "first line" of antitumor and antiviral protection in the early stages after аllogeneic hematopoietic stem cell transplantation. Quantitative characteristics reach normal values already in the first month after the infusion of blood stem cells to the r...
Volledige tekst
Artikel -
2
Impact of graft-versus-host disease prophylaxis on immune reconstitution in patients after allogeneic hematopoietic stem cell transplantation door E. D. Mikhaltsova, N. N. Popova, M. Yu. Drokov, N. M. Kapranov, Yu. O. Davydova, V. A. Vasilieva, D. S. Dubnyak, U. V. Maslikova, I. V. Galtseva, L. A. Kuzmina, E. N. Parovichnikova, V. G. Savchenko
Gepubliceerd in 2021-11-01The graft-versus-host disease (GVHD) is among the most common complications after hematopoietic stem cell transplantation (allo-HSCT). The main tools for GVHD prevention remain calcineurin inhibitors (cyclosporin A, tacrolimus), methotrexate, mycophenolate mofetil. Upon implementation of reduced-int...
Volledige tekst
Artikel